Yoneda, Kazue http://orcid.org/0000-0001-7142-2743
Kuwata, Taiji
Kanayama, Masatoshi
Mori, Masataka
Kawanami, Toshinori
Yatera, Kazuhiro
Ohguri, Takayuki
Hisaoka, Masanori
Nakayama, Toshiyuki
Tanaka, Fumihiro
Funding for this research was provided by:
UOEH Research Grant for Promotion of Occupational Health
MEXT | Japan Society for the Promotion of Science (16H10697, 16H01747)
Article History
Received: 23 March 2019
Revised: 7 July 2019
Accepted: 18 July 2019
First Online: 7 August 2019
Competing interests
: K.Y. reports grants from ASAHI KASEI PHARMA CORPORATION, grants and personal fees from Astellas Pharma Inc., grants and personal fees from AstraZeneca K.K., grants and personal fees from Bristol-Myers Squibb K.K., grants and personal fees from CHUGAI PHARMACEUTICAL CO., LTD., grants from DAIICHI SANKYO COMPANY, LIMITED, grants from Daiwa Securities Health Foundation, grants and personal fees from Eli Lilly Japan K.K., grants from FUJIFILM Pharma Co., Ltd., grants from Fukuda Denshi Co., Ltd., grants and personal fees from GlaxoSmithKline K.K., grants from KAKENHI (Grants-in-Aid for Scientific Research) (C), grants from KYORIN Pharmaceutical Co.,Ltd., grants from Kyowa Hakko Kirin Co., Ltd., grants from Meiji Seika, grants and personal fees from MSD K.K. a subsidiary of Merck & Co.,Inc., grants from Mylan Inc., grants from Nippon Boehringer lngelheim Co., Ltd., grants from North East, grants and personal fees from Novartis Pharma K.K., grants from ONO PHARMACEUTICAL CO., LTD., grants from Oxford Immunotec, Inc., grants and personal fees from Pfizer Inc., grants and personal fees from Shionogi & Co., Ltd., grants from Sumitomo Dainippon Pharma Co., Ltd., grants and personal fees from TAIHO Pharmaceutical Co., Ltd., grants and personal fees from Taisho Toyama Pharmaceutical Co., Ltd., grants and personal fees from TEIJIN HOME HEALTHCARE LIMITED., outside the submitted work. F.T. reports grants and personal fees from ASAHI KASEI PHARMA CO, grants from Astellas Pharma Inc., grants and personal fees from AstraZeneca K.K., personal fees from Bristol-Myers Squibb K.K., grants and personal fees from CHUGAI PHARMACEUTICAL CO., LTD., grants and personal fees from Eli Lilly Japan K.K., grants and personal fees from Kyowa Hakko Kirin Co., Ltd., grants and personal fees from MSD K.K., grants and personal fees from Novartis Pharma K.K., grants and personal fees from ONO PHARMACEUTICAL CO., LTD., personal fees from Pfizer Inc., grants and personal fees from Shionogi & Co., Ltd., grants and personal fees from TAIHO Pharmaceutical Co., Ltd., grants from Eizai Co. Ltd., grants and personal fees from Nippon Boehringer Ingelheim Co. Ltd., personal fees from Johnson & Johnson Co. Ltd., personal fees from Covidien Japan Co. Ltd., outside the submitted work. The remaining authors declare no competing interests.
: The institutional review board of the University of Occupational and Environmental Health, Japan approved the present study. This study was performed in accordance with the Declaration of Helsinki.
: This study was supported in part by the Japan Society for the Promotion of Science (JSPS) [Grants-in-Aid for Scientific Research Grant Numbers 16H10697 and 16H01747], UOEH Research Grant for Promotion of Occupational Health.
: Not applicable.
: Requests for data and reagents can be made by contacting the corresponding author.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).